𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐬𝐞𝐝 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞
𝐁𝐢𝐨𝐑𝐍 𝐢𝐬 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐧𝐨𝐰𝐧𝐞𝐝 𝐄𝐔 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐩𝐫𝐨𝐣𝐞𝐜𝐭 𝐏𝐑𝐄𝐂𝐈𝐒𝐄𝐔
👏 Exhiting news!
BioRN is one of 25 partner organisations from eleven European countries that are working together on the further development of tailored healthcare as part of the EU research project PRECISEU, short for
"Empowering Personalized Medicine connecting Innovation Regional Ecosystems Across Europe".
💡 The PRECISEU project will connect regions in Europe to share best practices and solutions and promote innovation in healthcare, focusing on advanced therapy medicinal products (ATMPs) and health data.
The five-year project is funded with a total of 22.7 million euros, half of which comes from the Horizon Europe initiative. It brings together regional authorities, academic institutions, non-governmental organisations and innovation actors. PRECISEU involves innovators, scientists and entrepreneurs in the participating countries, including Spain, Germany, Italy, Belgium, the Netherlands, Sweden, Greece, Romania, Bulgaria, Lithuania and Ukraine.
✅Gitte Neubauer, Chair of the board of BioRN says: "Participation in this consortium fits perfectly with our mission to act as a dynamic and innovative life sciences ecosystem beyond the borders of Germany".
✅ Julia Schaft, Managing Director of BioRN explains:"With our many years of expertise, we want to make a valuable contribution to this strategically important international project and play a decisive role in shaping the future of healthcare. This is a win-win situation for BioRN, as the region will further expand its leading position in personalised medicine."
Read the press release: https://lnkd.in/eiGMCQVV
#PrecisionMedicine #Innovation #Collaboration #HorizonEurope
BIOPRO Baden-Württemberg GmbH; BIO Deutschland e. V.;
Annalisa Zuccotti;André H.R. Domin;Health + Life Science Alliance